A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity

NCT01586117 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Amifostine

Sponsor

Chinese Academy of Medical Sciences